Style | Citing Format |
---|---|
MLA | Moeinafshar A, Razi S, Rezaei N. "Interleukin 17, the Double-Edged Sword in Atherosclerosis." Immunobiology, vol. 227, no. 3, 2022, pp. -. |
APA | Moeinafshar A, Razi S, Rezaei N (2022). Interleukin 17, the Double-Edged Sword in Atherosclerosis. Immunobiology, 227(3), -. |
Chicago | Moeinafshar A, Razi S, Rezaei N. "Interleukin 17, the Double-Edged Sword in Atherosclerosis." Immunobiology 227, no. 3 (2022): -. |
Harvard | Moeinafshar A, Razi S, Rezaei N (2022) 'Interleukin 17, the Double-Edged Sword in Atherosclerosis', Immunobiology, 227(3), pp. -. |
Vancouver | Moeinafshar A, Razi S, Rezaei N. Interleukin 17, the Double-Edged Sword in Atherosclerosis. Immunobiology. 2022;227(3):-. |
BibTex | @article{ author = {Moeinafshar A and Razi S and Rezaei N}, title = {Interleukin 17, the Double-Edged Sword in Atherosclerosis}, journal = {Immunobiology}, volume = {227}, number = {3}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Moeinafshar A AU - Razi S AU - Rezaei N TI - Interleukin 17, the Double-Edged Sword in Atherosclerosis JO - Immunobiology VL - 227 IS - 3 SP - EP - PY - 2022 ER - |